Plotting a global path to blockbuster sales, GSK grabs Shingrix nods in Europe, Japan
admin 23rd March 2018 Uncategorised 0As GlaxoSmithKline presses ahead with its Shingrix launch, the company picked up two important nods on Friday from regulators in Europe and Japan. These two leading drug markets are key to the shingles vaccine rollout already begun in the U.S. and Canada.
More: Plotting a global path to blockbuster sales, GSK grabs Shingrix nods in Europe, Japan
Source: fierce